Catalent to help Novo Nordisk address production demands for Ozempic and Wegovy: GlobalData EP News Bureau Feb 7, 2024 The acquisition of Catalent by Novo Holdings expects to see three new manufacturing sites added to Novo Nordisk’s arsenal, to…
Novo Nordisk Wegovy’s NHS access marks milestone in obesity treatment, but challenges remain:… EP News Bureau Oct 3, 2023 The constrained supply of Wegovy and the necessity of ongoing obesity management support are key considerations
